AMPLIFY Trademark

Trademark Overview

On Tuesday, March 18, 2008, a trademark application was filed for AMPLIFY with the United States Patent and Trademark Office. The USPTO has given the AMPLIFY trademark a serial number of 77424998. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, June 30, 2017. This trademark is owned by Bristol-Myers Squibb Company. The AMPLIFY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research, namely, conducting clinical trials relating to pharmaceutical preparations for human use
amplify

General Information

Serial Number77424998
Word MarkAMPLIFY
Filing DateTuesday, March 18, 2008
Status710 - CANCELLED - SECTION 8
Status DateFriday, June 30, 2017
Registration Number3880328
Registration DateTuesday, November 23, 2010
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 22, 2008

Trademark Statements

Goods and ServicesMedical and scientific research, namely, conducting clinical trials relating to pharmaceutical preparations for human use

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 30, 2017
Primary Code042
First Use Anywhere DateTuesday, June 10, 2008
First Use In Commerce DateTuesday, June 10, 2008

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10154
Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10154
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10154

Trademark Events

Event DateEvent Description
Friday, June 30, 2017CANCELLED SEC. 8 (6-YR)
Tuesday, April 19, 2011ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, April 19, 2011TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 23, 2010REGISTERED-PRINCIPAL REGISTER
Thursday, October 21, 2010NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED
Wednesday, October 20, 2010LAW OFFICE REGISTRATION REVIEW COMPLETED
Tuesday, October 19, 2010ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, September 28, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Monday, September 27, 2010STATEMENT OF USE PROCESSING COMPLETE
Thursday, September 23, 2010USE AMENDMENT FILED
Monday, September 27, 2010EXTENSION 4 GRANTED
Thursday, September 23, 2010EXTENSION 4 FILED
Thursday, September 23, 2010TEAS EXTENSION RECEIVED
Thursday, September 23, 2010TEAS STATEMENT OF USE RECEIVED
Monday, March 15, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Monday, March 15, 2010EXTENSION 3 GRANTED
Wednesday, March 10, 2010EXTENSION 3 FILED
Wednesday, March 10, 2010TEAS EXTENSION RECEIVED
Thursday, December 17, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 17, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, September 21, 2009EXTENSION 2 GRANTED
Wednesday, September 16, 2009EXTENSION 2 FILED
Wednesday, September 16, 2009TEAS EXTENSION RECEIVED
Wednesday, April 1, 2009EXTENSION 1 GRANTED
Thursday, March 12, 2009EXTENSION 1 FILED
Wednesday, April 1, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, March 12, 2009TEAS EXTENSION RECEIVED
Tuesday, October 14, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 22, 2008PUBLISHED FOR OPPOSITION
Wednesday, July 2, 2008NOTICE OF PUBLICATION
Tuesday, June 17, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, June 13, 2008ASSIGNED TO LIE
Friday, June 13, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, June 8, 2008ASSIGNED TO EXAMINER
Monday, March 24, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

amplify relating pharmaceutical preparations human trials clinical scientific research namely conducting